Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.
- Authors
- Landry, Joseph; Sharov, Alexei A; Piao, Yulan; Sharova, Lioudmila V; Xiao, Hua; Southon, Eileen; Matta, Jennifer; Tessarollo, Lino; Zhang, Ying E; Ko, Minoru S H; Kuehn, Michael R; Yamaguchi, Terry P; Wu, Carl
- Year
- 2008
- Journal
- PLoS genetics
- PMID
- 18974875
- DOI
- 10.1371/journal.pgen.1000241
- PMCID
- PMC2570622
We have characterized the biological functions of the chromatin remodeling protein Bptf (Bromodomain PHD-finger Transcription Factor), the largest subunit of NURF (Nucleosome Remodeling Factor) in a mammal. Bptf mutants manifest growth defects at the post-implantation stage and are reabsorbed by E8.5. Histological analyses of lineage markers show that Bptf(-/-) embryos implant but fail to establish a functional distal visceral endoderm. Microarray analysis at early stages of differentiation has identified Bptf-dependent gene targets including homeobox transcriptions factors and genes essential for the development of ectoderm, mesoderm, and both definitive and visceral endoderm. Differentiation of Bptf(-/-) embryonic stem cell lines into embryoid bodies revealed its requirement for development of mesoderm, endoderm, and ectoderm tissue lineages, and uncovered many genes whose activation or repression are Bptf-dependent. We also provide functional and physical links between the Bptf-containing NURF complex and the Smad transcription factors. These results suggest that Bptf may co-regulate some gene targets of this pathway, which is essential for establishment of the visceral endoderm. We conclude that Bptf likely regulates genes and signaling pathways essential for the development of key tissues of the early mouse embryo.
Bptf mutants manifest early embryonic growth defects.(A) Wild type (+/+), heterozygous (+/β), and homozygous (β/β)Bptf XG023 embryos at E5.5, E6.5, and E7.5 were removed from their decedua and genotyped using the PCR based method. Reduced growth rates are evident in the homozygous Bptf XG023 embryos as early as E5.5. (B) Hematoxylin and eosin (H&E) staining of E5.5, E6.5, and E7.5 mutant embryos show reduced growth of both embryonic and extra-embryonic tissues, the presence of visceral endoderm, and an absence of anteriorβposterior asymmetry when compared to controls. Bptf mutant embryos were stained for phosphorylated histone H3, a marker of cell mitosis. Mutant embryos at E5.5, E6.5, and E7.5 have significantly reduced staining when compared to controls, suggesting that they have reduced cellular proliferation. Bptf-mutant embryos were stained for apoptotic cells using the TUNEL assay. Mutant embryos at E5.5, E6.5, and E7.5 do not have any positive staining by TUNEL when compared to controls, suggesting that they are not apoptotic. Scale Bars: E5.5 and E6.5 embryos = 50 Β΅m, E7.5 embryos = 100 Β΅m. Abbreviations: ve, visceral endoderm; ee, embryonic ectoderm; m, mesoderm; xe, extra-embryonic ectoderm; xve, extra-embryonic visceral endoderm.
LLM interpretation
This figure consists of microscopy images comparing wild-type (+/+), heterozygous (+/β), and homozygous (β/β) *Bptf* mutant embryos across three developmental stages (E5.5, E6.5, and E7.5). Panel A shows a progressive reduction in overall embryo size in the homozygous mutants compared to controls. Panel B displays H&E staining showing reduced growth and loss of asymmetry in mutants, decreased phosphorylated histone H3 staining indicating reduced cell proliferation, and a lack of TUNEL-positive staining, indicating an absence of apoptosis.
Bptf mutants are defective in the expression of distal visceral endoderm markers.(A) Wild type embryos were stained in whole mount for Bptf mRNA by in situ RNA hybridization at E4.5, E5.5, and E6.5. Bptf is expressed in the inner cell mass and primitive endoderm at E4.5 and in the embryonic and extra-embryonic tissues in E5.5 and E6.5 embryos. Abbreviations: ve, visceral endoderm; ee, embryonic ectoderm; xe, extra-embryonic ectoderm; DVE, distal visceral endoderm. (B) Whole mount in situ RNA hybridization analysis of wild type and mutant E4.5 and E5.5 embryos for Nanog, Gata6, Lefty1, Cer1, Hex1, and Nodal expression. At E4.5, Bptf mutant embryos show expression of Nanog, Gata6, Lefty1, and Hex1, suggesting that the primitive endoderm and inner cell mass is present in Bptf mutants. Mutant E5.5 embryos are defective in the expression of DVE markers Cer1 and Hex1, suggesting that mutants cannot form the DVE. Interestingly, the general visceral endoderm marker GATA6 is not expressed in the VE but rather in the embryonic ectoderm at E5.5.
LLM interpretation
This figure consists of whole-mount in situ RNA hybridization images of mouse embryos. Panel A shows the expression pattern of *Bptf* mRNA across three developmental stages (E4.5, E5.5, and E6.5), with labels indicating localization in the embryonic ectoderm (ee), extra-embryonic ectoderm (xe), visceral endoderm (ve), and distal visceral endoderm (DVE). Panel B compares wild-type (+/+) and mutant (-/-) embryos at E4.5 and E5.5 for various markers, showing that while markers like *Nanog* and *Gata6* are present at E4.5, the mutant embryos exhibit a loss of DVE markers *Cer1* and *Hex1* by E5.5.
Analysis of Bptf knockout mouse embryonic stem cells shows severe defects in gene expression during embryoid differentiation.Relative expression of developmental markers during an embryoid body differentiation time course. The expression of many markers of the ectoderm (A), mesoderm (B), and endoderm (C) tissue lineages were severely defective in Bptf mutants during the differentiation time course.
LLM interpretation
This figure consists of three grouped bar charts (A, B, and C) showing the relative expression of ectoderm, mesoderm, and endoderm markers normalized to *Gapdh* over a 9-day differentiation time course. The data compares wild-type (+/+) and Bptf knockout (-/-) mouse embryonic stem cells across four time points (0, 2, 5, and 9 days). In all three panels, the expression levels of the majority of developmental markers are markedly reduced or absent in the Bptf mutant (-/-) compared to the wild-type (+/+) cells.
Analysis of Bptf knockout mouse embryonic stem cells shows severe defects in gene expression during differentiation with RA and LIF withdrawal. Bptf knockout embryonic stem (ES) cells were induced to differentiate using LIF withdrawal (LIFβ) or the addition of retinoic acid (RA), and gene expression was monitored by microarray. (A) Bptf-dependent genes were defined as genes whose transcription increases or decreases more than 2-fold in the mutant compared to the wild type with a FDR value of <0.05. (B) A manual clustering analysis of Bptf-dependent genes by condition of dependence and expression values. Six expression categories were identified and include genes which are exclusively Bptf-dependent in LIFβ, LIF+, or RA conditions, genes which are dependent in all conditions (constitutive regulation), genes which are dependent in 2 conditions (complex regulation), or genes which vary in direction of misregulation between conditions (mixed regulation). (C) Clustering analysis of Bptf-dependent genes important for the development of tissue lineages of the early embryo. Bptf is essential for the proper regulation of many markers of ectoderm, endoderm, and mesoderm tissue lineages.
LLM interpretation
This figure consists of three panels analyzing gene expression in Bptf knockout mouse embryonic stem cells. Panel A uses Venn diagrams to show the overlap of activated (red) and repressed (green) Bptf-dependent genes across three conditions: LIF+, LIFβ, and RA. Panel B is a hierarchical clustering heatmap showing six categories of Bptf-dependent gene regulation (LIF+, LIFβ, RA, Constitutive, Complex, and Mixed) across the same conditions, with a color scale from green (<0.2) to red (>5.0). Panel C is a heatmap displaying the expression of specific marker genes categorized by tissue lineage (Ectoderm, Endoderm, Mesoderm, Extra-Embryonic, and Pluripotency) across the three conditions.
Bptf is necessary for Smad mediated gene regulation.(A) RT-PCR analysis of known Smad target genes from activin-A induced wild type (+/+) and Bptf knockout (β/β) embryonic stem (ES) cells shows Cer1, T, Gsc to be dependent, and Fgf8, Lefty1 to be partially dependent on Bptf for full activation. (B) Like CBP/p300, Bptf regulates Smad-dependent genes in vivo. Bptf or CBP/p300 were knocked down in activin-A induced or uninduced ES cells. The expression of gene targets was determined by RT-PCR and is expressed as a ratio of induced/uninduced for each knockdown condition. Lefty1, Fgf8, T, Gsc, and Cer1 require both Bptf and CBP/p300 for full activin-Aβdependent gene activation. (C) NURF interacts with the Smad transcription factors in vitro. Recombinant NURF complex was subjected to GST pull-down assays using resin bound GST, GST-Smads, GST-Smad fragments, and GST-Ξ²-catenin. GST-Smad2 and 3 but not GST and GST-Ξ²-catenin controls can specifically pull down the NURF complex. The GST-Smad2C containing the C-terminal fragment of Smad2 specifically pulls down the NURF complex. The C-terminal domain of Smad2 interacts with native NURF from crude nuclei extracts. High salt nuclei extracts from ES cells was subjected to GST pull-down assays using resin bound GST and GST-Smad fragments. The GST-Smad2C containing the C-terminal fragment of Smad2 specifically pulls down the Bptf and Snf2h/l components of the native NURF complex and the histone acetyl-transferase CBP from nuclei extracts. (D) Chromatin immunoprecipation of Snf2h/l and histone modifications 3me-K4H3 and 3me-K27H3 at Lefty1 show recruitment of the Snf2h/l subunit to the neural plate specific enhancer (NPE), a region which contains Smad binding elements, in a Bptf and an activin-Aβdependent manner. Snf2h/l ChIP is expressed as a ratio of induced (+activin-A) to uninduced (βactivin A). Histone modifications are shown during induced (+activin-A) conditions for +/+ and β/β cells and have been normalized to a pan histone H3 pulldown. NPE = neural plate specific enhancer, LPE = lateral plate specific enhancer, RSS = right side specific enhancer.
LLM interpretation
This figure consists of four panels (A-D) analyzing the role of Bptf in Smad-mediated gene regulation. Panels A and B are bar charts showing that the expression of Smad target genes (*Lefty1, Fgf8, T, Gsc, Cer1*) is reduced in Bptf knockout or BPTF/p300 siRNA knockdown ES cells following Activin-A induction. Panel C displays GST pull-down assays (protein blots) demonstrating that the NURF complex (Bptf, SNF2H/L) and CBP interact with Smad2/3 and the C-terminal fragment of Smad2. Panel D includes a genomic map of the *Lefty1* locus and corresponding bar charts showing that Bptf is required for the recruitment of SNF2H/L and the enrichment of H3K4-3me at the neural plate specific enhancer (NPE/P2), while H3K27-3me levels remain relatively unchanged.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | 2014 | 24315570 |
| Chromatin remodelling during development. | 2010 | 20110991 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Bromodomain-Driven Regulation of Stem Cells: A Potential Target for Cancer Therapeutic Intervention. | Jothi M et al. | β | 2026 | β |
| BPTF promotes glioma development through USP34-mediated de-ubiquitination of FOXC1. | Pan Y et al. | β | 2025 | β |
| BPTF regulates androgen receptor activity by enhancing chromatin accessibility and stabilizing the AR-FOXA1 interaction. | Jeon HY et al. | β | 2025 | β |
| Chromatin remodeling protein BPTF mediates chromatin accessibility at gene promoters in planarian stem cells. | Verma P et al. | β | 2025 | β |
| Cyclical Vomiting Syndrome in Individuals With BPTF Haploinsufficiency. | Ferretti A et al. | β | 2025 | β |
| Epigenetic control of cell identities from epiblast to gastrulation. | SchΓΌle KM et al. | β | 2025 | β |
| Loss of BPTF restores estrogen response and suppresses metastasis of mammary tumors. | Ciccone MF et al. | β | 2025 | β |
| A role of BPTF in viral oncogenicity delineated through studies of heritable Kaposi sarcoma. | Yogev Y et al. | β | 2024 | β |
| Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors. | Khan I et al. | β | 2024 | β |
| Copy number variants selected during pig domestication inferred from whole genome resequencing. | Zhang W et al. | β | 2024 | β |
| Differential requirements for Smarca5 expression during hematopoietic stem cell commitment. | Turkova T et al. | β | 2024 | β |
| Effect of bromodomain PHD-finger transcription factor (BPTF) on trophoblast epithelial-to-mesenchymal transition. | Pan L et al. | β | 2024 | β |
| moSCminer: a cell subtype classification framework based on the attention neural network integrating the single-cell multi-omics dataset on the cloud. | Choi JM et al. | β | 2024 | β |
| O-GlcNAc transferase congenital disorder of glycosylation (OGT-CDG): Potential mechanistic targets revealed by evaluating the OGT interactome. | Mayfield JM et al. | β | 2024 | β |
| Roles and Regulation of H3K4 Methylation During Mammalian Early Embryogenesis and Embryonic Stem Cell Differentiation. | Terzi ΓizmecioΔlu N | β | 2024 | β |
| An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions. | Radzisheuskaya A et al. | β | 2023 | β |
| Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review. | Czerwinska P et al. | β | 2023 | β |
| Discovery of a Chemical Probe to Study Implications of BPTF Bromodomain Inhibition in Cellular and inβ vivo Experiments. | Martinelli P et al. | β | 2023 | β |
| Discovery of new small molecule inhibitors of the BPTF bromodomain. | Liang X et al. | β | 2023 | β |
| HMGXB4 Targets <i>Sleeping Beauty</i> Transposition to Germinal Stem Cells. | Devaraj A et al. | β | 2023 | β |
| The effect of growth hormone treatment in children with novel BPTF gene variants: A report of two cases and literature review. | Wu W et al. | β | 2023 | β |
| When Dad's Stress Gets under Kid's Skin-Impacts of Stress on Germline Cargo and Embryonic Development. | Kretschmer M et al. | β | 2023 | β |
| BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A. | Guo P et al. | β | 2022 | β |
| BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target. | Bezrookove V et al. | β | 2022 | β |
| Generation of a mouse model of the neurodevelopmental disorder with dysmorphic facies and distal limb anomalies syndrome. | Zapata G et al. | β | 2022 | β |
| Identification of genetic polymorphisms in unexplained recurrent spontaneous abortion based on whole exome sequencing. | Mou JT et al. | β | 2022 | β |
| Identification of the Inner Cell Mass and the Trophectoderm Responses after an In Vitro Exposure to Glucose and Insulin during the Preimplantation Period in the Rabbit Embryo. | Via Y Rada R et al. | β | 2022 | β |
| Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR). | MuΓ±oz Velasco R et al. | β | 2022 | β |
| Autophagy-Dependent Sensitization of Triple-Negative Breast Cancer Models to Topoisomerase II Poisons by Inhibition of the Nucleosome Remodeling Factor. | Tyutyunyk-Massey L et al. | β | 2021 | β |
| hnRNPLL controls pluripotency exit of embryonic stem cells by modulating alternative splicing of Tbx3 and Bptf. | Wang X et al. | β | 2021 | β |
| Impaired SNF2L Chromatin Remodeling Prolongs Accessibility at Promoters Enriched for Fos/Jun Binding Sites and Delays Granule Neuron Differentiation. | Goodwin LR et al. | β | 2021 | β |
| New Design Rules for Developing Potent Cell-Active Inhibitors of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition. | Zahid H et al. | β | 2021 | β |
| Opportunity knocks for uncovering the new function of an understudied nucleosome remodeling complex member, the bromodomain PHD finger transcription factor, BPTF. | Zahid H et al. | β | 2021 | β |
| Organization of the Pluripotent Genome. | Lim PSL et al. | β | 2021 | β |
| Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies. | Glinton KE et al. | β | 2021 | β |
| Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease. | Alendar A et al. | β | 2021 | β |
| Synthesis of NVS-BPTF-1 and evaluation of its biological activity. | MΓ©lin L et al. | β | 2021 | β |
| ATP-Dependent Chromatin Remodeling Complex in the Lineage Specification of Mesenchymal Stem Cells. | Du W et al. | β | 2020 | β |
| Bptf determines oncogenic addiction in aggressive B-cell lymphomas. | Richart L et al. | β | 2020 | β |
| BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway. | Green AL et al. | β | 2020 | β |
| Chromatin regulation and dynamics in stem cells. | Klein DC et al. | β | 2020 | β |
| Combined Protein- and Ligand-Observed NMR Workflow to Screen Fragment Cocktails against Multiple Proteins: A Case Study Using Bromodomains. | Johnson JA et al. | β | 2020 | β |
| HIF-1Ξ±/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells. | Cui P et al. | β | 2020 | β |
| NMR Analyses of Acetylated H2A.Z Isoforms Identify Differential Binding Interactions with the Bromodomain of the NURF Nucleosome Remodeling Complex. | Olson NM et al. | β | 2020 | β |
| Patterns of malformation associated with esophageal atresia/tracheoesophageal fistula: A retrospective single center study. | Galarreta CI et al. | β | 2020 | β |
| BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits. | Zhao X et al. | β | 2019 | β |
| Bromodomain PHDβfinger transcription factor promotes glioma progression and indicates poor prognosis. | Pan Y et al. | β | 2019 | β |
| circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression. | Zhan W et al. | β | 2019 | β |
| Evolution of Yin and Yang isoforms of a chromatin remodeling subunit precedes the creation of two genes. | Xu W et al. | β | 2019 | β |
| Genomic and phenotypic delineation of congenital microcephaly. | Shaheen R et al. | β | 2019 | β |
| Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor. | Kirberger SE et al. | β | 2019 | β |
| Chromatin remodeling in mammalian embryos. | Cabot B et al. | β | 2018 | β |
| Crosstalk between TGF-Ξ² signaling and epigenome. | Bai J et al. | β | 2018 | β |
| Mitochondrially produced ATP affects stem cell pluripotency via Actl6a-mediated histone acetylation. | Zhang Y et al. | β | 2018 | β |
| Molecular regulation of Nodal signaling during mesendoderm formation. | Wei S et al. | β | 2018 | β |
| NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy. | Roussy M et al. | β | 2018 | β |
| Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis. | Caforio M et al. | β | 2018 | β |
| The Chromatin Remodeler BPTF Activates a Stemness Gene-Expression Program Essential for the Maintenance of Adult Hematopoietic Stem Cells. | Xu B et al. | β | 2018 | β |
| The role of ISWI chromatin remodeling complexes in brain development and neurodevelopmental disorders. | Goodwin LR et al. | β | 2018 | β |
| BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. | Mayes K et al. | β | 2017 | β |
| BPTF Maintains Chromatin Accessibility and the Self-Renewal Capacity of Mammary Gland Stem Cells. | Frey WD et al. | β | 2017 | β |
| Distinct modes of SMAD2 chromatin binding and remodeling shape the transcriptional response to NODAL/Activin signaling. | Coda DM et al. | β | 2017 | β |
| Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features. | Stankiewicz P et al. | β | 2017 | β |
| Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression. | Liu B et al. | β | 2017 | β |
| SET1A/COMPASS and shadow enhancers in the regulation of homeotic gene expression. | Cao K et al. | β | 2017 | β |
| The Epigenetic Paradox of Pluripotent ES Cells. | Festuccia N et al. | β | 2017 | β |
| A Role for the Chromatin-Remodeling Factor BAZ1A in Neurodevelopment. | Zaghlool A et al. | β | 2016 | β |
| ATP-dependent chromatin remodeling during mammalian development. | Hota SK et al. | β | 2016 | β |
| BPTF Depletion Enhances T-cell-Mediated Antitumor Immunity. | Mayes K et al. | β | 2016 | β |
| BPTF Is Essential for T Cell Homeostasis and Function. | Wu B et al. | β | 2016 | β |
| BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis. | Richart L et al. | β | 2016 | β |
| Ino80 is essential for proximal-distal axis asymmetry in part by regulating Bmp4 expression. | Qiu Z et al. | β | 2016 | β |
| BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma. | Xiao S et al. | β | 2015 | β |
| BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas. | Dai M et al. | β | 2015 | β |
| Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells. | Koludrovic D et al. | β | 2015 | β |
| Embryonic stem cell differentiation requires full length Chd1. | Piatti P et al. | β | 2015 | β |
| Functional interactions between NURF and Ctcf regulate gene expression. | Qiu Z et al. | β | 2015 | β |
| Multi-layered global gene regulation in mouse embryonic stem cells. | Beck S et al. | β | 2015 | β |
| The Chromatin Remodeling Protein Bptf Promotes Posterior Neuroectodermal Fate by Enhancing Smad2-Activated wnt8a Expression. | Ma Y et al. | β | 2015 | β |
| The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin. | Xiao S et al. | β | 2015 | β |
| The role of BPTF in melanoma progression and in response to BRAF-targeted therapy. | Dar AA et al. | β | 2015 | β |
| ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells. | Zhu P et al. | β | 2015 | β |
| ATP-dependent chromatin remodeling complexes as novel targets for cancer therapy. | Mayes K et al. | β | 2014 | β |
| Chromatin dynamics: interplay between remodeling enzymes and histone modifications. | Swygert SG et al. | β | 2014 | β |
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | Agrawal A et al. | β | 2014 | β |
| Epigenetics of cancer stem cells: Pathways and therapeutics. | Shukla S et al. | β | 2014 | β |
| INO80 facilitates pluripotency gene activation in embryonic stem cell self-renewal, reprogramming, and blastocyst development. | Wang L et al. | β | 2014 | β |
| Snf2h-mediated chromatin organization and histone H1 dynamics govern cerebellar morphogenesis and neural maturation. | Alvarez-Saavedra M et al. | β | 2014 | β |
| TGF-Ξ² signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation. | Gaarenstroom T et al. | β | 2014 | β |
| A hierarchy in reprogramming capacity in different tissue microenvironments: what we know and what we need to know. | Liebau S et al. | β | 2013 | β |
| Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. | Liang G et al. | β | 2013 | β |
| Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. | Watanabe A et al. | β | 2013 | β |
| ATP-dependent chromatin remodeling in T cells. | Wurster AL et al. | β | 2012 | β |
| CECR2 is involved in spermatogenesis and forms a complex with SNF2H in the testis. | Thompson PJ et al. | β | 2012 | β |
| Chromatin-remodeling complex specificity and embryonic vascular development. | Curtis CD et al. | β | 2012 | β |
| Early cardiac development: a view from stem cells to embryos. | Van Vliet P et al. | β | 2012 | β |
| Oct4 links multiple epigenetic pathways to the pluripotency network. | Ding J et al. | β | 2012 | β |
| Ab initio identification of transcription start sites in the Rhesus macaque genome by histone modification and RNA-Seq. | Liu Y et al. | β | 2011 | β |
| ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. | Hargreaves DC et al. | β | 2011 | β |
| CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes. | Potts RC et al. | β | 2011 | β |
| Chromatin remodeling complex NURF regulates thymocyte maturation. | Landry JW et al. | β | 2011 | β |
| Chromatin remodelling in mammalian cells by ISWI-type complexes--where, when and why? | Erdel F et al. | β | 2011 | β |
| Chromatin structure of pluripotent stem cells and induced pluripotent stem cells. | Delgado-OlguΓn P et al. | β | 2011 | β |
| Epigenetic modifications of stem cells: a paradigm for the control of cardiac progenitor cells. | Zhou Y et al. | β | 2011 | β |
| Global identification of SMAD2 target genes reveals a role for multiple co-regulatory factors in zebrafish early gastrulas. | Liu Z et al. | β | 2011 | β |
| Open chromatin in pluripotency and reprogramming. | Gaspar-Maia A et al. | β | 2011 | β |
| Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells. | Myers SA et al. | β | 2011 | β |
| Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. | Ruthenburg AJ et al. | β | 2011 | β |
| The nucleosome remodeling factor. | Alkhatib SG et al. | β | 2011 | β |
| Trithorax group proteins: switching genes on and keeping them active. | Schuettengruber B et al. | β | 2011 | β |
| ATP dependent chromatin remodeling enzymes in embryonic stem cells. | Saladi SV et al. | β | 2010 | β |
| Chromatin plasticity and genome organization in pluripotent embryonic stem cells. | Mattout A et al. | β | 2010 | β |
| Chromatin regulatory mechanisms in pluripotency. | Lessard JA et al. | β | 2010 | β |
| Chromatin remodelling during development. | Ho L et al. | β | 2010 | β |
| Control of embryonic stem cell identity by nucleosome remodeling enzymes. | Fazzio TG et al. | β | 2010 | β |
| Epigenetic regulation of stem cell maintenance in the Drosophila testis via the nucleosome-remodeling factor NURF. | Cherry CM et al. | β | 2010 | β |
| Gene expression profiling of mouse embryos with microarrays. | Sharov AA et al. | β | 2010 | β |
| Global chromatin architecture reflects pluripotency and lineage commitment in the early mouse embryo. | Ahmed K et al. | β | 2010 | β |
| Redox control in mammalian embryo development. | Ufer C et al. | β | 2010 | β |
| The SNF2H chromatin remodeling enzyme has opposing effects on cytokine gene expression. | Precht P et al. | β | 2010 | β |